trending Market Intelligence /marketintelligence/en/news-insights/trending/8ztyed2vceos-lwdg6xyga2 content esgSubNav
In This List

IBio completes 1-for-10 reverse stock split

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


IBio completes 1-for-10 reverse stock split

IBio Inc. said June 8 that its number of shares was reduced to about 11.6 million from about 115.9 million through a previously announced reverse stock split.

The 1-for-10 reverse stock split was implemented June 8, and the New York biotechnology company's shares will start trading June 11 on a split-adjusted basis.

IBio said its stock will continue to trade on the NYSE American under the symbol IBIO.

Continental Stock Transfer & Trust Co. acted as transfer agent and exchange agent for the reverse stock split.